Search results
Results from the WOW.Com Content Network
SSRIs and SNRIs have been shown to be effective in treating major depressive disorder and anxiety in pediatric populations. [95] However, differences in metabolism, renal function, and total percentage of body water and body fat can influence the pharmacokinetics of medications in youths as compared to adults. [96]
For example, cocaine, which non-selectively inhibits the reuptake of serotonin, norepinephrine, and dopamine, is an SRI but not an SSRI. SRIs are used predominantly as antidepressants (e.g., SSRIs, SNRIs, and TCAs), though they are also commonly used in the treatment of other psychological conditions such as anxiety disorders and eating disorders.
No difference risk of suicide attempts was detected between SSRIs versus tricyclic antidepressants. [ 135 ] A 2006 review suggests that the widespread use of antidepressants in the new "SSRI-era" appears to have led to a highly significant decline in suicide rates in most countries with traditionally high baseline suicide rates.
Full Antidepressants List: SSRIs, SNRIs, TCAs & Others If you’ve been diagnosed with depression, your healthcare provider may have suggested antidepressant medication to relieve symptoms like ...
Other antidepressants include monoamine oxidase inhibitors , serotonin-norepinephrine reuptake inhibitors (SNRIs), atypical antidepressants and tricyclic antidepressants . Lots of acronyms, we know.
Effectiveness and side effect rates can vary between SSRIs. As such, your healthcare provider may suggest switching to a different SSRI, even if you currently use this type of antidepressant ...
Noradrenergic and specific serotonergic antidepressants (NaSSAs) are a class of psychiatric drugs used primarily as antidepressants. [1] They act by antagonizing the α 2 -adrenergic receptor and certain serotonin receptors such as 5-HT 2A and 5-HT 2C , [ 1 ] but also 5-HT 3 , [ 1 ] 5-HT 6 , and/or 5-HT 7 in some cases.
To date, a great number of potent and selective and mixed norepinephrine reuptake inhibitors (NRIs) have been marketed as antidepressants. [11] The first commercially available selective norepinephrine reuptake inhibitor (sNRI) was reboxetine (Edronax) and was developed as a first-line therapy for major depressive disorder. [29]